UNSPSC 51281609: Daptomycin

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NWQ5N31VKK. European Medicines Agency schedules Daptomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06910MIG. Daptomycin generally arises in the molecular formula C72H101N17O26.

The term DAPTOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) DAPTOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule daptomycin under HS 29419000 and SITC 54139. As of Q4 2014, DAPTOMYCIN remains the US FDA Preferred Term for this commodity. Daptomycin bears US NLM identifiers UMLS ID C0057144 and NCI Concept Code C47470.

UNSPSC 51281609 Daptomycin is a Commodity code that classifies individual pharmaceutical products, though the recent state and local opportunities posted under this code do not reflect daptomycin procurement specifically. Instead, the tagged solicitations cover antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and naloxone with drug deactivation systems—suggesting misalignment between the code assignment and actual pharmaceutical categories being procured. State and local health departments and counties use codes in this family to source prescription medications and emergency medical supplies through both direct purchase and piggyback arrangements leveraging cooperative purchasing consortia such as MMCAP Infuse. Issuing bodies include state health departments, county health authorities, and public health districts; the recent record shows the Illinois Department of Public Health and Seminole County, Florida as active buyers in the pharmaceutical supply space.

The geographic spread in recent activity spans at least Illinois and Florida. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets valued at $2,999,999.11 over 36 months including renewals, selected as the lowest priced responsive and responsible bidder under an IFB process. Seminole County, Florida released an IFB (number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though the listed response deadline of July 26, 2023, appears to be a historical artifact in the source data and does not reflect current opportunity status. Both procurements require vendor compliance with E-Verify and drug-free workplace certification, and the Seminole County procurement includes potential FEMA funding with associated federal compliance obligations.